164 results
Page 7 of 9
6-K
EX-99.1
rwgb8sb9hxc4xe nzs
20 Oct 15
First Participants Enrolled in RepliCel's Phase 1 Clinical Trial of its RCS-01 Dermatology Injectable
12:00am
6-K
EX-99.1
20jc7zfu73hn
23 Jul 15
RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
12:00am
6-K
EX-99.1
hqy5 p6w51wpl
23 Feb 15
RepliCel Submits Clinical Trial Application for its Dermatological Product
12:00am
6-K
EX-99.1
h321 8u1f7pyqh
21 Jan 15
RepliCel Life Sciences to Present at 11th Annual Phacilitate Cell & Gene Therapy Forum in Washington, DC
12:00am
6-K
EX-99.1
6gdhweb8h
7 Jan 15
RepliCel Life Sciences to Present at Biotech Showcase 2015 in San Francisco
12:00am
6-K
EX-99.1
35nvs2mhwbz1lzc6x
22 Dec 14
Current report (foreign)
12:00am
6-K
EX-99.1
x7c9of
1 Dec 14
RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis
12:00am
6-K
EX-99.1
5ykrrc
26 Nov 14
RepliCel Announces 2014 Third Quarter Financial Results
12:00am
6-K
EX-99.1
h2vddm
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
d0vr2ceh h1
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
gktkxc lfzxmg5yjgz
29 Oct 14
RepliCel Submits Clinical Trial Application to Health Canada for its Chronic Achilles Tendinosis Trial
12:00am
6-K
EX-99.1
978i7yzd21dmj
9 Oct 14
RepliCel to Present Commercial and Clinical Update at BioJapan 2014 World Business Forum
12:00am
6-K
EX-99.1
14vfaf
7 Oct 14
RepliCel Life Sciences Adds Industry Specialist to Management Team
12:00am
6-K
EX-99.1
ku3cqglnzfmm5x9a
2 Oct 14
Replicel Life Sciences 6-K
12:00am
6-K
EX-99.1
2x7o6km3qwqqg 9th919
15 Sep 14
Replicel Life Sciences 6-K
12:00am
6-K
EX-99.1
68wlz6kr3y
9 Sep 14
Replicel Life Sciences Inc. 6-K
12:00am
6-K
EX-99.1
q4hrazcdo0 8g6
4 Sep 14
RepliCel to Present at Rodman & Renshaw’s 16th Annual
12:00am
6-K
EX-99.1
2lb01m4a5 41xtkrf3h9
3 Sep 14
RepliCel Life Sciences Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium
12:00am
6-K
EX-99.2
2hzmkl ytagfkze
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am